Respect Human Rights
Committed to maintaining and enhancing the health, safety, and daily comfort of people around the world, the SHIONOGI Group aims to create a brighter future through better healthcare, always at the service of our four stakeholders: our patients, physicians and other healthcare providers, our shareholders and investors, and the general public.
In recent years, the severity of human rights issues and demands for responses to them have increased due to the globalization of business and the expansion of supply chains. Having clarified its stance on further expanding its business globally under the Medium-Term Business Plan—Shionogi Transformation Strategy 2030 Revision (STS2030 Revision) —SHIONOGI is promoting initiatives while recognizing that it is important to respect human rights, not only as a responsibility that a company must fulfill but also when implementing management strategies.
To promote the prevention and reduction of human rights risk, we will identify global human rights issues with the cooperation of an external expert on human rights*1, while advancing our efforts toward building a human rights due diligence system.
*1 Caux Round Table Japan (Global network of business leaders working to realize a fair, free and transparent society through sustainable and socially responsible business)
Human Rights Policy
Human Rights Due Diligence
Comment from the external expert
Dialogue
Governance
Supply Chain
Healthcare workers, Patient and their families
Remedy
Human Rights Policy
Human Rights Due Diligence
30 classified risks
- Safety in clinical trials
- Access to healthcare
- Fair price
- Development costs/Development risks
- Drug safety, side effects, and health hazards
- Prevention of counterfeit medicines
- Adequate and appropriate explanations to patients (transparency)
- Improper disposal of pharmaceuticals and medical supplies
- Ethical marketing
- Contribution to health outcomes
- Public health/Pandemic response
- Securing and developing human resources
- Supply chain management
- Corporate ethics and compliance with laws
- Protection of privacy and personal data
- Anti-corruption
- Relationship with government
- Forced labor
- Migrant workers
- Child labor
- Discrimination/equal opportunity
- Fair wages
- Working time
- Freedom of association
- Occupational health and safety
- Grievance mechanism
- Environmental burden reduction/Environmental impact
- Management of hazardous substances and chemical sub stances
- Use of natural resources
- Community support (social contribution activities)
In addition, we examined specific practical risks for each item based on the impact on society and the relationship with our business. As a result, we identified issues in understanding risks related to "Labor situation in the production areas of raw and other materials" and " Labor situation of foreign workers ." From FY2021, we are implementing specific activities to precisely understand risks.
In FY2022, we focused on addressing the identified risks and not reviewed any risks. Furthermore, in order to incorporate external opinions, we participated in the Stakeholder Engagement Program*2 sponsored by the Nippon CSR Consortium, and exchanged opinions with NGOs/NPOs. Through engagement with members of civil society, we examined “important human rights issues for each industry.” We have not identified any new items to be reflected in our risk table, but we will continue to incorporate opinions from outside of SHIONOGI and consider revising risks as necessary.
*2 CRT-Japan » Human Rights Due Diligence Workshop(External site)
Theme |
Results for 2021 |
Remaining issues |
Activities for 2022 |
Progress in 2022 |
[Labor situation in the production areas of raw and other materials] Important items (cellulose, glass, ethanol, aluminum) |
・Impact assessment of Indian farmers regarding eucalyptus, one of the raw materials for cellulose ・Survey on human rights risks in the supply chain for cellulose |
Survey of human rights risks in the supply chain for glass, ethanol, and aluminum | Direct communication with the major suppliers for glass, ethanol and aluminum | ・Exchanged opinions on human rights risks at raw material suppliers, and grasped raw materials and manufacturing regions for one new item ・Confirmed to work together when a negative impact becomes apparent |
[Labor situation in the production areas of raw and other materials] Forced labor in rubber glove manufacturing in Malaysia |
― |
Grasping the track record of use of the relevant products within our group |
Investigate whether products purchased through direct suppliers are manufactured by the relevant company |
・There is a past purchase record ・Confirmed that we are currently purchasing or using none of the relevant products |
[Labor situation of foreign workers] Supply chain for the therapeutic drugs and preventive vaccines for COVID-19 |
Survey the labor situation of technical intern trainees within our group and confirmation that no technical intern trainees are accepted |
Understanding the working conditions of foreign technical interns in the supply chain of major products |
Survey of 7 major suppliers of the therapeutic drugs and preventive vaccines for COVID-19 |
Confirmed that no technical intern trainees were accepted by any of the suppliers |
As a result of the FY2022 assessment, no risks were materialized.
Therefore, we have not taken any mitigating, corrective or remedial action.
Dialogue with experts
Employee
Workshop
In 2020, SHIONOGI Group held workshops on Business and Human Rights for our officers and employees in cooperation with CRT Japan. They learned about "United Nations Guiding Principles on Business and Human Rights" and listed up our Human Rights issues by themselves. This risk map is used effectively for our human rights due diligence process.